Dr. Fasahat Husain Hamzavi, MD

Dr. Hamzavi practices at Hamzavi Dermatology in Fort Gratiot, Michigan.

Dr. Hamzavi's NPI, 1295780989, was assigned on May 23, 2006. Dr. Hamzavi graduated from Wayne State University School of Medicine in 2000. Dr. Hamzavi holds Michigan license FH078231.

Dr. Hamzavi's primary practice is Hamzavi Dermatology, at 2950 Keewahdin Rd, Fort Gratiot, MI 48059 in Saint Clair County. The practice phone is (586) 286-8720.

Dr. Hamzavi's primary practice is Hamzavi Dermatology in Fort Gratiot, Michigan. Dr. Hamzavi is also affiliated with McLaren Port Huron. The medical group on file is Hamzavi Dermatology. Dmand AI also links Dr. Hamzavi to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamzavi practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Hamzavi's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Hamzavi is licensed in Michigan.

CMS data shows 10,377 Medicare services from Dr. Hamzavi across 34 procedure codes in 2024, for 2,024 Medicare patients. Medicare paid $500,089 for them. Every service was in an office.

CMS counts 2,024 Medicare patients who saw Dr. Hamzavi in 2024. The largest group is 65 to 74, with 882 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hamzavi's median patient age at 67, with 57% women.

In 2024, Dr. Hamzavi wrote 869 Medicare Part D claims for 442 patients. 91% of them were for generic drugs. CMS names the drug for 725 of them, across 18 drugs with 11 or more claims each, at $259,089 in total drug cost. In 2023, CMS named 538 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Hamzavi for performance year 2024, reported individually. Dr. Hamzavi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 3,520 procedures of removal of skin lesions by Dr. Hamzavi, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Hamzavi in 2010. Dr. Hamzavi's most frequent co-author is Jugpal Arneja, MD.

Dmand AI links Dr. Hamzavi to 7 clinical trials, 3 of them phase 3 studies. Conditions studied include Eczema, Acneiform Eruptions and Alopecia Areata. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Hamzavi that name 3 trials.

CMS Open Payments shows 179 general payments to Dr. Hamzavi from 28 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 44% of the total. Insmed, Inc. paid the most, $1,850. It also lists 27 research payments totaling $233,606 from 2016 to 2025, naming 3 clinical trials.

Dr. Hamzavi graduated from Wayne State University School of Medicine in 2000.